Fractional Flow Reserve Market to Reach $2,558.34 million, Globally, by 2035 at 9.1% CAGR: Allied Market Research

/EIN News/ -- Wilmington, Delaware, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Fractional Flow Reserve Market by Product (Guidewires, Monitoring Systems, Accessories, and Software), Technology (Invasive Monitoring and Non invasive Monitoring), Application (Single vessel CAD and Multi vessel CAD), and End User (Hospitals, Cardiac Centres, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "fractional flow reserve market" was valued at $901.3 million in 2023, and is estimated to reach $2,558.34 million by 2035, growing at a CAGR of 9.1% from 2024 to 2035. 

Rise in prevalence of cardiovascular diseases, favorable reimbursement policies, availability of guidelines for FFR, and growth in demand for minimally invasive & non-invasive procedures are the major factors that drive the growth of the fractional flow reserve market. 

Request Sample of the Report on Global Fractional Flow Reserve Market 2035 - https://www.alliedmarketresearch.com/request-sample/A10446 

Prime determinants of growth  

Rise in prevalence of cardiovascular diseases, favorable reimbursement policies, availability of guidelines for FFR, and growth in demand for minimally invasive & non-invasive procedures are the major factors that drive the growth of the fractional flow reserve market. However, high cost of FFR procedures and devices restrict market growth. Moreover, high growth potential in emerging countries and advancements in FFR technology are expected to present new opportunities in the coming years.  

Report coverage & details:  

Report Coverage	Details
Forecast Period	2024–2035
Base Year	2023
Market Size in 2023	$901.3 million
Market Size in 2035	$2,558.34 million
CAGR	9.1%
No. of Pages in Report	350
Segments covered	Product, Technology, Application, End User, and Region
Drivers	Rise in prevalence of cardiovascular diseases                 Favorable reimbursement policies                 Availability of guidelines for FFR                 Growing demand for minimally invasive & non-invasive procedures
Opportunities	High growth potential in emerging countries                 Advancements in FFR
Restraint	High cost of FFR procedures and devices

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A10446 

The guidewires segment held the largest market share in 2023.  

By product, the guidewires segment held the largest market share in 2023, accounting for nearly half of the fractional flow reserve market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the essential role guidewires play in facilitating accurate measurements during FFR assessments. They enable the precise delivery of pressure sensors, which are crucial for assessing blood flow in coronary arteries. However, the monitoring systems segment is expected to register the highest CAGR of 9.5% during the forecast period. This is attributed to an increase in integration of advanced technologies, such as artificial intelligence (AI) and machine learning, which enhance the accuracy and efficiency of fractional flow reserve (FFR) assessments.  

The invasive monitoring segment held the largest market share in 2023.  

By technology, the invasive monitoring segment held the largest market share in 2023, accounting for nearly four-fifths of the fractional flow reserve market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to its established role of invasive procedures as the gold standard for assessing fractional flow reserve (FFR) during coronary procedures. However, the non-invasive monitoring segment is expected to register the highest CAGR of 9.5% during the forecast period. This is attributed to growing demand for safer diagnostic alternatives that minimize patient discomfort and reduce recovery times. Non-invasive techniques, such as fractional flow reserve computed tomography (FFR-CT), provide accurate assessments of coronary artery health without the need for catheterization, making them appealing to both patients and healthcare providers.  

The single vessel CAD segment held the largest market share in 2023.  

By application, the single vessel CAD segment held the largest market share in 2023, accounting for around three-fifths of the fractional flow reserve market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to rise in prevalence of coronary artery blockages that require precise evaluation to guide treatment decisions. The effectiveness of FFR in assessing the severity of single vessel lesions helps clinicians determine the necessity for intervention, leading to better patient outcomes.  

However, the multi vessel CAD segment is expected to register the highest CAGR of 9.3% during the forecast period. This is attributed to the increasing complexity of coronary artery disease cases, where multiple blockages need precise assessment and management. As awareness grows regarding the importance of accurately evaluating multi-vessel lesions for optimal treatment strategies, the adoption of fractional flow reserve (FFR) technology in this segment is accelerating.  

The hospitals segment held the largest market share in 2023.  

By end user, the hospitals segment held the largest market share in 2023, accounting for around three-fourths of the fractional flow reserve market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is expected to register the highest CAGR of 9.3% during the forecast period. This is attributed to high volume of cardiovascular procedures performed in hospitals, where FFR technology is routinely utilized for accurate diagnosis and treatment planning.  

North America held the largest market share in 2023.  

North America dominated the market share in 2023, accounting for two-fifths of the fractional flow reserve market revenue, owing to regional benefits from a well-established healthcare infrastructure and advanced technological capabilities, facilitating the widespread adoption of FFR technology. In addition, the increase in prevalence of coronary artery disease, coupled with a growing aging population, drives the demand for accurate diagnostic tools such as FFR.  

However, Asia-Pacific is expected to register the highest CAGR of 9.7% during the forecast period owing to the rapid growth of healthcare infrastructure and increase in investments in medical technologies across the region. The rising prevalence of cardiovascular diseases, driven by lifestyle changes and an aging population, led to a greater demand for advanced diagnostic tools such as fractional flow reserve (FFR).  

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A10446 

Leading Market Players:   

• Haemonetics Corporation  

• Abbott Laboratories  

• Boston Scientific Corporation  

• Bracco  

• Koninklijke Philips N.V.  

• HeartFlow, Inc.  

• Esaote Group  

• CathWorks  

• Siemens  

• GE HealthCare  

The report provides a detailed analysis of these key players in the fractional flow reserve market. These players have adopted strategies such as acquisition, expansion, product approvals, product launch, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario. 

Trending Reports in Healthcare Industry:  

Point of Care Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2023-2032 

Contraceptives Market - Global Opportunity Analysis and Industry Forecast, 2023-2032 

Electrophysiology Market - Global Opportunity Analysis and Industry Forecast, 2023-2032 

Orphan Drugs Market - Global Opportunity Analysis and Industry Forecast, 2023-2032 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter